出血性卒中：回眸2022

doi:10.3969/j.issn.1673-5765.2023.01.003

摘要/Abstract

关键词: 出血性卒中; 脑出血; 脑淀粉样血管病; 卒中相关肺炎; 脑海绵状血管畸形; 癫痫; 血压; 血肿

边立衡, 鞠奕, 熊云云, 王文娟, 王锦锦, 刘丽君, 李光硕, 林怡君, 赵性泉. 出血性卒中：回眸2022[J]. 中国卒中杂志, 2023, 18(01): 42-53.

BIAN Liheng, JU Yi, XIONG Yunyun, WANG Wenjuan, WANG Jinjin, LIU Lijun, LI Guangshuo, LIN Yijun, ZHAO Xingquan. Highlights in Hemorrhagic Stroke in 2022 [J]. Chinese Journal of Stroke, 2023, 18(01): 42-53.

参考文献

[1] CHARIDIMOU A，BOULOUIS G，FROSCH M P，et al. The Boston criteria version 2.0 for cerebral amyloid angiopathy：a multicentre，retrospective，MRI-neuropathology diagnostic accuracy study[J]. The Lancet Neurology，2022，21（8）：714-725.
[2] BEAUDIN A E，MCCREARY C R，MAZEROLLE E L，et al. Cerebrovascular reactivity across the entire brain in cerebral amyloid angiopathy[J/OL]. Neurology，2022，98（17）：e1716-e1728[2023-01-20]. https://doi.org/10.1212/wnl. 0000000000200136.
[3] HOSTETTLER I C，SEIFFGE D，WONG A，et al. APOE and cerebral small vessel disease markers in patients with intracerebral hemorrhage[J/OL]. Neurology，2022，99（12）：e1290-e1298[2023-01-20]. https://doi.org/10.1212/wnl.0000000000200851.
[4] ZUURBIER S M，HICKMAN C R，RINKEL L A，et al. Association between beta-blocker or statin drug use and the risk of hemorrhage from cerebral cavernous malformations[J]. Stroke，2022，53（8）：2521-2527.
[5] TEH W H，SMITH C J，BARLAS R S，et al. Impact of stroke-associated pneumonia on mortality，length of hospitalization，and functional outcome[J]. Acta Neurol Scand，2018，138（4）：293-300.
[6] JI R J，WANG D，SHEN H P，et al. Interrelationship among common medical complications after acute stroke：pneumonia plays an important role[J]. Stroke，2013，44（12）：3436-3444.
[7] KWAN J，PICKERING R M，KUNKEL D，et al. Impact of stroke-associated infection on long-term survival：a cohort study[J]. J Neurol Neurosurg Psychiatry，2013，84（3）：297-304.
[8] JI R J，LIU Y F，LIU X Y，et al. Comparison of clinical scores for predicting stroke-associated pneumonia after intracerebral hemorrhage（ICH）：potential tools for personalized care and clinical trials for ICH[J/OL]. Ann Transl Med，2022，10（7）：397[2023-01-20]. https://doi.org/10.21037/atm-21-4046.
[9] YAN J，ZHAI W Q，LI Z X，et al. ICH-LR2S2：a new risk score for predicting stroke-associated pneumonia from spontaneous intracerebral hemorrhage[J/OL]. J Transl Med，2022，20（1）：193[2023-01-20]. https://doi.org/10.1186/s12967-022-03389-5.
[10] TSAI H H，HSIEH Y C，LIN J S，et al. Functional investigation of meningeal lymphatic system in experimental intracerebral hemorrhage[J]. Stroke，2022，53（3）：987-998.
[11] REHNI A K，CHO S，QUERO H N，et al. Red blood cell microparticles limit hematoma growth in intracerebral hemorrhage[J]. Stroke，2022，53（10）：3182-3191.
[12] MOULLAALI T J，WANG X，SANDSET E C，et al. Early lowering of blood pressure after acute intracerebral haemorrhage：a systematic review and meta-analysis of individual patient data[J]. J Neurol Neurosurg Psychiatry，2022，93（1）：6-13.
[13] PSZCZOLKOWSKI S，SPRIGG N，WOODHOUSE L J，et al. Effect of tranexamic acid administration on remote cerebral ischemic lesions in acute spontaneous intracerebral hemorrhage：a substudy of a randomized clinical trial[J]. JAMA Neurol，2022，79（5）：468-477.
[14] OH S E，MURTHY S B. Tranexamic acid and diffusion-weighted imaging lesions after intracerebral hemorrhage[J]. JAMA Neurol，2022，79（5）：447-449.
[15] RUIZ-SANDOVAL JL，CHIQUETE E，ROMERO-VARGAS S，et al. Grading scale for prediction of outcome in primary intracerebral hemorrhages[J]. Stroke，2007，38（5）：1641-1644.
[16] GREGSON B A，BRODERICK J P，AUER L M，et al. Individual patient data subgroup meta-analysis of surgery for spontaneous supratentorial intracerebral hemorrhage[J]. Stroke，2012，43（6）：1496-1504.
[17] SELIM M，FOSTER L D，MOY C S，et al. Deferoxamine mesylate in patients with intracerebral haemorrhage（i-DEF）：a multicentre，randomised，placebo-controlled，double-blind phase 2 trial[J]. Lancet Neurol，2019，18（5）：428-438.
[18] WEI C C，WANG J，FOSTER L D，et al. Effect of deferoxamine on outcome according to baseline hematoma volume：a post hoc analysis of the i-def trial[J]. Stroke，2022，53（4）：1149-1156.
[19] DE HERDT V，DUMONT F，HÉNON H，et al. Early seizures in intracerebral hemorrhage: incidence，associated factors，and outcome[J]. Neurology，2011，77（20）：1794-1800.
[20] BEGHI E，CARPIO A，FORSGREN L，et al. Recommendation for a definition of acute symptomatic seizure[J]. Epilepsia，2010，51（4）：671-675.
[21] CLAASSEN J，JETTÉ N，CHUM F，et al. Electrographic seizures and periodic discharges after intracerebral hemorrhage[J]. Neurology，2007，69（13）：1356-1365.
[22] LAW Z K，ENGLAND T J，MISTRI A K，et al. Incidence and predictors of early seizures in intracerebral haemorrhage and the effect of tranexamic acid[J]. Eur Stroke J，2020，（2）：123-129.
[23] GILAD R，BOAZ M，DABBY R，et al. Are post intracerebral hemorrhage seizures prevented by anti-epileptic treatment?[J]. Epilepsy Res，2011，95（3）：227-231.
[24] PETER-DEREX L，FRÉDÉRIC F，GARNIER P，et al. Safety and efficacy of prophylactic levetiracetam for prevention of epileptic seizures in the acute phase of intracerebral haemorrhage（peach）：a randomised，double-blind，placebo-controlled，phase 3 trial[J]. Lancet Neurol，2022，21（9）：781-791.
[25] SOLNICKY V，ZIAI W C. Seizure prevention in patients with intracerebral haemorrhage[J]. Lancet Neurol，2022，21（9）：760-761.